These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Cardiac regeneration therapy: connections to cardiac physiology. Takehara N; Matsubara H Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2169-80. PubMed ID: 21963835 [TBL] [Abstract][Full Text] [Related]
9. Stem cell therapy for acute myocardial infarction: on the horizon or still a dream? Fish KM; Ishikawa K; Hajjar RJ Coron Artery Dis; 2018 Mar; 29(2):89-91. PubMed ID: 29140809 [No Abstract] [Full Text] [Related]
10. Cellular cardiomyoplasty--cardiomyocytes, skeletal myoblasts, or stem cells for regenerating myocardium and treatment of heart failure? Reffelmann T; Kloner RA Cardiovasc Res; 2003 May; 58(2):358-68. PubMed ID: 12757870 [No Abstract] [Full Text] [Related]
11. Stem cell therapy in patients with heart failure. Vrtovec B; Poglajen G; Haddad F Methodist Debakey Cardiovasc J; 2013; 9(1):6-10. PubMed ID: 23518819 [TBL] [Abstract][Full Text] [Related]
12. Myocardial cell sheet therapy and cardiac function. Fujita J; Itabashi Y; Seki T; Tohyama S; Tamura Y; Sano M; Fukuda K Am J Physiol Heart Circ Physiol; 2012 Nov; 303(10):H1169-82. PubMed ID: 23001836 [TBL] [Abstract][Full Text] [Related]
14. Cardiomyocyte Regeneration: A Consensus Statement. Eschenhagen T; Bolli R; Braun T; Field LJ; Fleischmann BK; Frisén J; Giacca M; Hare JM; Houser S; Lee RT; Marbán E; Martin JF; Molkentin JD; Murry CE; Riley PR; Ruiz-Lozano P; Sadek HA; Sussman MA; Hill JA Circulation; 2017 Aug; 136(7):680-686. PubMed ID: 28684531 [No Abstract] [Full Text] [Related]
15. Potential Strategies for Clinical Translation of Repeated Cell Therapy. Vrtovec B; Bolli R Circ Res; 2019 Mar; 124(5):690-692. PubMed ID: 30817255 [TBL] [Abstract][Full Text] [Related]
16. Cardiac stem cell trials and the new world of cellular reprogramming: Time to move on. Rosengart TK; Patel V; Sellke FW J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1642-1646. PubMed ID: 29397153 [No Abstract] [Full Text] [Related]
17. A new direction for cardiac regeneration therapy: application of synergistically acting epicardium-derived cells and cardiomyocyte progenitor cells. Winter EM; van Oorschot AA; Hogers B; van der Graaf LM; Doevendans PA; Poelmann RE; Atsma DE; Gittenberger-de Groot AC; Goumans MJ Circ Heart Fail; 2009 Nov; 2(6):643-53. PubMed ID: 19919990 [TBL] [Abstract][Full Text] [Related]
18. MY APPROACH to stem cell therapy for heart failure patients: Not all cells are created equally. Cingolani E Trends Cardiovasc Med; 2019 Aug; 29(6):374. PubMed ID: 30928315 [No Abstract] [Full Text] [Related]
19. Pluripotent stem cell-derived cardiomyocytes for treatment of cardiomyopathic damage: Current concepts and future directions. Garbern JC; Escalante GO; Lee RT Trends Cardiovasc Med; 2021 Feb; 31(2):85-90. PubMed ID: 31983535 [TBL] [Abstract][Full Text] [Related]
20. Human heart failure: is cell therapy a valid option? Rota M; Leri A; Anversa P Biochem Pharmacol; 2014 Mar; 88(2):129-38. PubMed ID: 24239645 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]